Results 311 to 320 of about 1,093,427 (365)
Some of the next articles are maybe not open access.
The Lancet Oncology, 2019
BACKGROUND Stereotactic ablative body radiotherapy (SABR) is widely used to treat inoperable stage 1 non-small-cell lung cancer (NSCLC), despite the absence of prospective evidence that this type of treatment improves local control or prolongs overall ...
David Ball +24 more
semanticscholar +1 more source
BACKGROUND Stereotactic ablative body radiotherapy (SABR) is widely used to treat inoperable stage 1 non-small-cell lung cancer (NSCLC), despite the absence of prospective evidence that this type of treatment improves local control or prolongs overall ...
David Ball +24 more
semanticscholar +1 more source
Clinical Orthopaedics and Related Research, 1975
Radiation therapy in the treatment of osteosarcoma has been considered with respect of the subclinical metastatic disease in the lung and the primary lesion. Emphasis is given to the necessity of coordinating the management plan of the primary lesion with an adjuvant program.
openaire +2 more sources
Radiation therapy in the treatment of osteosarcoma has been considered with respect of the subclinical metastatic disease in the lung and the primary lesion. Emphasis is given to the necessity of coordinating the management plan of the primary lesion with an adjuvant program.
openaire +2 more sources
Radiotherapy and molecular radiotherapy
2005Abstract Radiotherapy is the use of ionizing radiation (IR) to treat malignant diseases, by damaging and killing tumour cells, for tumour cure or palliation of symptoms. Radiotherapy may also be used in cer- tain benign conditions such as keloid scars, hyper- ostotic new bone formation, and hyperthyroidism.
openaire +1 more source
Emerging evidence for adapting radiotherapy to immunotherapy
Nature Reviews Clinical Oncology, 2023L. Galluzzi +3 more
semanticscholar +1 more source
The British Journal of Radiology, 1952
In an endeavour to enlarge the scope of radiotherapy and to improve the results of treatment by a new method, it is imperative to state clearly some of the basic principles underlying the suggested procedure. It seems appropriate therefore to uphold certain fundamentals of radiobiology briefly and to scrutinise whether at any point our present-day ...
openaire +2 more sources
In an endeavour to enlarge the scope of radiotherapy and to improve the results of treatment by a new method, it is imperative to state clearly some of the basic principles underlying the suggested procedure. It seems appropriate therefore to uphold certain fundamentals of radiobiology briefly and to scrutinise whether at any point our present-day ...
openaire +2 more sources
Veterinary Clinics of North America: Small Animal Practice, 1997
Palliative radiation therapy can be useful in controlling the pain associated with tumors for which definitive therapy is not an option. The patient's quality of life is improved while side effects, hospitalization, and cost of treatment are minimized. Palliative radiation therapy should be considered as part of the oncologist's armamentarium; however,
S, Siegel, K L, Cronin
openaire +2 more sources
Palliative radiation therapy can be useful in controlling the pain associated with tumors for which definitive therapy is not an option. The patient's quality of life is improved while side effects, hospitalization, and cost of treatment are minimized. Palliative radiation therapy should be considered as part of the oncologist's armamentarium; however,
S, Siegel, K L, Cronin
openaire +2 more sources
Journal of the American Veterinary Medical Association, 1970
SUMMARY Spontaneous animal tumors of several cell types were irradiated. A 2-year cure-rate was established for tumors in each of 4 cell types by determining the percentage nonrecurrence at 2 years following radiotherapy. The 2-year cure-rates were as follows: perianal tumors, 69%; fibrosarcomas, 56%; squamous cell carcinomas, 74%; and mast cell tumors,
openaire +2 more sources
SUMMARY Spontaneous animal tumors of several cell types were irradiated. A 2-year cure-rate was established for tumors in each of 4 cell types by determining the percentage nonrecurrence at 2 years following radiotherapy. The 2-year cure-rates were as follows: perianal tumors, 69%; fibrosarcomas, 56%; squamous cell carcinomas, 74%; and mast cell tumors,
openaire +2 more sources
Towards clinical translation of FLASH radiotherapy
Nature Reviews Clinical Oncology, 2022M. Vozenin, J. Bourhis, M. Durante
semanticscholar +1 more source
Radiotherapy of paragangliomas
Clinical Otolaryngology, 1984From 1964 to 1980 28 patients with extensive paragangliomas were treated with radiation therapy. Nine patients had a carotid body tumour and 19 had a temporal bone tumour. During the 16 year period the radiation dose was gradually reduced from 60 Gy in 6 weeks to 40 Gy in 4 weeks. Continuous tumour control was achieved in all patients (follow-up 1.5-18
M L, Lybeert +4 more
openaire +2 more sources